Permethrin

The five exact strengths have current official SPC coverage and active Georgian veterinary registrations with exact authorisation numbers; independent field evidence is available.

The combination provides strong flea and tick control plus clinically useful repellent activity against multiple vectors, supported by field studies; duration and performance vary by parasite species, exposure and wetting.

Canine tolerability is generally good, but permethrin exposure can be fatal to cats; transient skin, behavioural, gastrointestinal and rare neurologic reactions are recognised, and the product is highly hazardous to aquatic organisms.

A weight-banded pipette gives roughly monthly protection, but correct multi-spot skin application, drying, temporary separation from cats, bathing constraints and epidemiology-based retreatment require more technique than a simple oral dose.

The five exact strengths have current official SPC coverage and active Georgian veterinary registrations with exact authorisation numbers; independent field evidence is available.

The combination provides strong flea and tick control plus clinically useful repellent activity against multiple vectors, supported by field studies; duration and performance vary by parasite species, exposure and wetting.

Canine tolerability is generally good, but permethrin exposure can be fatal to cats; transient skin, behavioural, gastrointestinal and rare neurologic reactions are recognised, and the product is highly hazardous to aquatic organisms.

A weight-banded pipette gives roughly monthly protection, but correct multi-spot skin application, drying, temporary separation from cats, bathing constraints and epidemiology-based retreatment require more technique than a simple oral dose.

The five exact strengths have current official SPC coverage and active Georgian veterinary registrations with exact authorisation numbers; independent field evidence is available.

The combination provides strong flea and tick control plus clinically useful repellent activity against multiple vectors, supported by field studies; duration and performance vary by parasite species, exposure and wetting.

Canine tolerability is generally good, but permethrin exposure can be fatal to cats; transient skin, behavioural, gastrointestinal and rare neurologic reactions are recognised, and the product is highly hazardous to aquatic organisms.

A weight-banded pipette gives roughly monthly protection, but correct multi-spot skin application, drying, temporary separation from cats, bathing constraints and epidemiology-based retreatment require more technique than a simple oral dose.

The five exact strengths have current official SPC coverage and active Georgian veterinary registrations with exact authorisation numbers; independent field evidence is available.

The combination provides strong flea and tick control plus clinically useful repellent activity against multiple vectors, supported by field studies; duration and performance vary by parasite species, exposure and wetting.

Canine tolerability is generally good, but permethrin exposure can be fatal to cats; transient skin, behavioural, gastrointestinal and rare neurologic reactions are recognised, and the product is highly hazardous to aquatic organisms.

A weight-banded pipette gives roughly monthly protection, but correct multi-spot skin application, drying, temporary separation from cats, bathing constraints and epidemiology-based retreatment require more technique than a simple oral dose.

The five exact strengths have current official SPC coverage and active Georgian veterinary registrations with exact authorisation numbers; independent field evidence is available.

The combination provides strong flea and tick control plus clinically useful repellent activity against multiple vectors, supported by field studies; duration and performance vary by parasite species, exposure and wetting.

Canine tolerability is generally good, but permethrin exposure can be fatal to cats; transient skin, behavioural, gastrointestinal and rare neurologic reactions are recognised, and the product is highly hazardous to aquatic organisms.

A weight-banded pipette gives roughly monthly protection, but correct multi-spot skin application, drying, temporary separation from cats, bathing constraints and epidemiology-based retreatment require more technique than a simple oral dose.

The exact product is registered in Georgia (000877, valid to 2030) with a current AVZ instruction; glucaminopropylcarbacridone is a Russian 'immunomodulator' with no international authorisation, and the only efficacy data are the manufacturer's.

Permethrin has some acaricidal action, but no independent evidence supports 0.05% for 3-7 days against ear mites, and no credible evidence shows that the acridone component helps otitis.

At this low concentration permethrin is low risk for dogs; the label excludes a perforated eardrum, safety data for the acridone component are limited, and treated dogs can expose cats in the household.

Three to five drops per ear once daily for up to a week is easy, but both ears and all in-contact animals need treatment.

The product carries a feline label in Georgia (000877), but no internationally recognised regulator authorises it for cats, and VetMan does not accept post-Soviet instructions as enough evidence for permethrin use in cats.

No independent evidence supports 0.05% permethrin against ear mites in cats, and the immunomodulator claim is unproven.

Cats metabolise permethrin poorly and can develop tremor, seizures and death; even a low ear dose adds risk through grooming and repeated application, with no proven benefit.

The drops are easy to instil, but VetMan shows no feline dose and authorised feline acaricides are readily available.

The exact 4.7/1.2 mg/g 150 ml presentation is actively registered in Georgia and has a current EU regulator SPC. Documentation is detailed, but independent exact-combination clinical trials are sparse and the foreign SPC includes additional non-food species beyond the Georgian dog presentation.

The label provides broad ectoparasite treatment, immature-stage activity and up to four weeks against fleas and ticks. Permethrin class evidence is credible, but exact permethrin/fenoxycarb comparative evidence is thin and whole-coat underdosing may reduce efficacy and select resistance.

The label reports very rare but potentially neurologic and systemic reactions. Cats must not be exposed; aerosol inhalation and skin/eye exposure require PPE and ventilation, fenoxycarb is flagged as a potential human carcinogen, and both actives are hazardous to aquatic life.

Dose depends on weight, coat length and density and requires whole-body spraying, combing or massage to the skin. Gloves, sometimes eye/respiratory protection, ventilation, 24-hour child exclusion, 48-hour no-bath and two-day no-swim rules make use demanding.

The exact 4.8/1.2 mg/g 150 ml dog foam is actively registered in Georgia and has a current regulator-linked SPC. Documentation is detailed, but independent exact-combination clinical trials are sparse and persistence is explicitly unproven.

The combination has plausible adult and immature-stage activity and a broad treatment label, but the label states that duration against individual parasites has not been demonstrated. It should therefore be judged for parasites present at treatment, not assumed to provide a monthly prevention interval.

Rare intoxication can include coat loss, vomiting, tremor, convulsion or slowed breathing. Cats, young puppies and pregnant or lactating bitches are excluded; whole-coat handler contact, a pressurised flammable container and aquatic toxicity add material risk.

The tennis-ball-sized foam amount is adjusted by animal size and spread over the whole body to the skin, without a precise measurable dose or demonstrated retreatment interval. Gloves, ventilation, 24-hour child exclusion and 48-hour no-bath handling are burdensome.

The exact 6.0/1.5 mg/g 150 ml presentation is actively registered in Georgia and has a current EU regulator document. Exact-combination independent trials are sparse, and the foreign record includes some additional non-food species beyond the Georgian dog presentation.

The combination has plausible adult and immature-stage activity and a broad treatment label, but the current instruction does not establish a retreatment interval or persistent duration. Class evidence cannot substitute for exact-product residual-efficacy data.

Very rare reactions may be neurologic or systemic. Cats, sick animals, young puppies, pregnancy and lactation are excluded; whole-coat spray exposure, handler precautions, flammability and aquatic toxicity materially constrain safe use.

The amount depends on coat length and density and requires whole-body spraying, combing or massage to the skin without a precise measurable regimen. PPE, ventilation, drying, 24-hour child exclusion, 48-hour no-bath and two-day no-swim rules are demanding.

All four exact presentations are registered in Georgia and covered by current regulator-hosted product literature, valid multinational authorisations and a transparent exact-product hybrid dossier with dose-confirmation studies.

Exact-product GCP studies support four-week flea activity and persistent efficacy against the labelled ticks, while applicable controlled and field studies support the imidacloprid-permethrin vector role. Immediate tick efficacy was not demonstrated, duration varies by target and bites or transmission are not completely prevented.

Healthy dogs tolerated the label dose and even five-fold overdose well in the dossier, with very rare canine reactions. The clinically important limits are potentially fatal feline permethrin exposure, reproductive uncertainty linked to N-methylpyrrolidone and aquatic toxicity.

A single-site weight-band pipette provides roughly monthly control and is straightforward, but drying, cat separation, bathing timing, vector-onset limitations and seasonal repeat treatment still require planning.

All four exact presentations are registered in Georgia and covered by current regulator-hosted product literature, valid multinational authorisations and a transparent exact-product hybrid dossier with dose-confirmation studies.

Exact-product GCP studies support four-week flea activity and persistent efficacy against the labelled ticks, while applicable controlled and field studies support the imidacloprid-permethrin vector role. Immediate tick efficacy was not demonstrated, duration varies by target and bites or transmission are not completely prevented.

Healthy dogs tolerated the label dose and even five-fold overdose well in the dossier, with very rare canine reactions. The clinically important limits are potentially fatal feline permethrin exposure, reproductive uncertainty linked to N-methylpyrrolidone and aquatic toxicity.

A single-site weight-band pipette provides roughly monthly control and is straightforward, but drying, cat separation, bathing timing, vector-onset limitations and seasonal repeat treatment still require planning.

All four exact presentations are registered in Georgia and covered by current regulator-hosted product literature, valid multinational authorisations and a transparent exact-product hybrid dossier with dose-confirmation studies.

Exact-product GCP studies support four-week flea activity and persistent efficacy against the labelled ticks, while applicable controlled and field studies support the imidacloprid-permethrin vector role. Immediate tick efficacy was not demonstrated, duration varies by target and bites or transmission are not completely prevented.

Healthy dogs tolerated the label dose and even five-fold overdose well in the dossier, with very rare canine reactions. The clinically important limits are potentially fatal feline permethrin exposure, reproductive uncertainty linked to N-methylpyrrolidone and aquatic toxicity.

A weight-band pipette provides roughly monthly control, but four-site application, drying, cat separation, bathing timing, vector-onset limitations and seasonal repeat treatment add meaningful handling steps.

All four exact presentations are registered in Georgia and covered by current regulator-hosted product literature, valid multinational authorisations and a transparent exact-product hybrid dossier with dose-confirmation studies.

Exact-product GCP studies support four-week flea activity and persistent efficacy against the labelled ticks, while applicable controlled and field studies support the imidacloprid-permethrin vector role. Immediate tick efficacy was not demonstrated, duration varies by target and bites or transmission are not completely prevented.

Healthy dogs tolerated the label dose and even five-fold overdose well in the dossier, with very rare canine reactions. The clinically important limits are potentially fatal feline permethrin exposure, reproductive uncertainty linked to N-methylpyrrolidone and aquatic toxicity.

A weight-band pipette provides roughly monthly control, but four-site application, drying, cat separation, bathing timing, vector-onset limitations and seasonal repeat treatment add meaningful handling steps.

The exact four-pipette dog pack has current Georgian authorisation through 2031, an approved manufacturer instruction and a current Russian umbrella registration. Exact identity is verifiable, but there is no EU/GB/US authorisation or public exact-product regulator assessment; the umbrella feline wording is not accepted as feline evidence.

Fipronil supports a plausible flea/tick/lice core, but no exact-product outcomes support the two-month insect, mite, ear or mange breadth. At the label rule, permethrin is about 0.95 mg/kg versus roughly 60-120 mg/kg in authorised comparators, so their repellency/acaricidal trial results cannot validate Chistotel.

Dog irritation, salivation/lacrimation and ingestion-related neurologic toxicity are material, and repeated bilateral ear-canal use lacks a tympanic/ototoxicity boundary. Permethrin creates potentially fatal household-cat risk. Exact quantified dog target-animal, reproductive and repeated-course safety data are absent.

Monthly skin dosing and clear weight bands are workable, but the 4 ml carton is insufficient for one dose above 40 kg and a 0.5 ml small-dog dose requires partial use of a 1 ml tube. Multi-site large-dog application, 48-hour contact/water controls and complex ear/mange repeats add burden.

The exact 0.4%, 180 ml juvenile presentation is actively registered in Georgia and has a detailed current manufacturer instruction. The Georgian source historically recorded a 40% strength while the exact instruction states 0.4%; that 100-fold conflict lowers source confidence, and no recognised-regulator dossier or independent exact-product trial was found.

Permethrin is an established contact insecticide and current authorised dog shampoos support a rinse-off role against fleas. The exact instruction also claims lice and chewing lice, but no controlled exact-product outcome study was found. A shampoo treats parasites present during bathing and cannot by itself control the environmental flea life cycle or provide long-lasting protection.

The rinse-off 0.4% canine regimen is usable from eight weeks according to the exact instruction, but no independent margin-of-safety study was found. It excludes pregnancy/lactation and weakened, emaciated, infectious or convalescent animals. Feline exposure remains a serious hard stop despite the source label naming kittens.

Apply 0.5-1 ml/kg to the wetted coat, lather, prevent licking and eye exposure, wait 5-7 minutes, rinse thoroughly, dry and comb. It is feasible but requires full-body bathing and restraint; repeat treatment still needs a parasite and environmental plan rather than automatic shampooing.

The exact 715 mg/1 ml presentation is actively registered in Georgia and has a current detailed AEMPS SPC; independent literature supports canine permethrin, while exact-product comparative trials are limited.

The label supports four weeks against fleas and ticks, three weeks of mosquito insecticidal activity and one week of sand-fly repellency. Class evidence is credible, but protection duration varies by vector and occasional attachment or biting means transmission cannot be excluded.

Canine adverse events are very rare but include local, gastrointestinal, behavioural and neurologic effects. Cat exposure can be fatal; strict 72-hour separation, handler precautions, insecticide exclusions and aquatic protection materially constrain safe use.

A fixed pipette is convenient below 15 kg, but dogs from 15-30 kg require two pipettes at two sites. Exact weighing, 72-hour cat separation, drying, child-contact and swimming restrictions add substantial household workflow.

The exact 1430 mg/2 ml, 15-30 kg presentation is actively registered in Georgia and has a current detailed AEMPS SPC; independent literature supports canine permethrin, while exact-product comparative trials are limited.

The label supports four weeks against fleas and ticks, three weeks of mosquito insecticidal activity and one week of sand-fly repellency. Class evidence is credible, but duration varies by vector and pathogen transmission cannot be excluded.

Canine adverse events are very rare but include local, gastrointestinal, behavioural and neurologic effects. Cat exposure can be fatal; strict 72-hour separation, handler precautions, insecticide exclusions and aquatic protection materially constrain safe use.

One weight-matched pipette divided between two sites is more convenient than two small pipettes for a 15-30 kg dog. Exact weighing, 72-hour cat separation, drying, child-contact and swimming restrictions still add household burden.

All five exact presentations are currently registered in Georgia, with a current regulator-hosted product-line leaflet, a transparent assessment dossier and exact-form evidence.

The regulatory dossier and several exact-product controlled or field studies consistently support four-week flea and tick activity plus anti-feeding activity against labelled sand flies and mosquitoes. Some studies are sponsor-linked and bites or attachment are not completely prevented.

Correctly selected dogs generally tolerate the label dose well and canine reactions are very rare, but neurologic signs are possible and permethrin exposure can be fatal to cats. Strict species separation, age, weight, illness and reproductive-use restrictions materially shape safe use.

Monthly weight-band dosing is workable, but application to two to four skin sites, drying time, cat separation, licking prevention and swimming or shampoo restrictions create more handling burden than a simple single-site ectoparasiticide.

All five exact presentations are currently registered in Georgia, with a current regulator-hosted product-line leaflet, a transparent assessment dossier and exact-form evidence.

The regulatory dossier and several exact-product controlled or field studies consistently support four-week flea and tick activity plus anti-feeding activity against labelled sand flies and mosquitoes. Some studies are sponsor-linked and bites or attachment are not completely prevented.

Correctly selected dogs generally tolerate the label dose well and canine reactions are very rare, but neurologic signs are possible and permethrin exposure can be fatal to cats. Strict species separation, age, weight, illness and reproductive-use restrictions materially shape safe use.

Monthly weight-band dosing is workable, but application to two to four skin sites, drying time, cat separation, licking prevention and swimming or shampoo restrictions create more handling burden than a simple single-site ectoparasiticide.

All five exact presentations are currently registered in Georgia, with a current regulator-hosted product-line leaflet, a transparent assessment dossier and exact-form evidence.

The regulatory dossier and several exact-product controlled or field studies consistently support four-week flea and tick activity plus anti-feeding activity against labelled sand flies and mosquitoes. Some studies are sponsor-linked and bites or attachment are not completely prevented.

Correctly selected dogs generally tolerate the label dose well and canine reactions are very rare, but neurologic signs are possible and permethrin exposure can be fatal to cats. Strict species separation, age, weight, illness and reproductive-use restrictions materially shape safe use.

Monthly weight-band dosing is workable, but application to two to four skin sites, drying time, cat separation, licking prevention and swimming or shampoo restrictions create more handling burden than a simple single-site ectoparasiticide.

All five exact presentations are currently registered in Georgia, with a current regulator-hosted product-line leaflet, a transparent assessment dossier and exact-form evidence.

The regulatory dossier and several exact-product controlled or field studies consistently support four-week flea and tick activity plus anti-feeding activity against labelled sand flies and mosquitoes. Some studies are sponsor-linked and bites or attachment are not completely prevented.

Correctly selected dogs generally tolerate the label dose well and canine reactions are very rare, but neurologic signs are possible and permethrin exposure can be fatal to cats. Strict species separation, age, weight, illness and reproductive-use restrictions materially shape safe use.

Monthly weight-band dosing is workable, but application to two to four skin sites, drying time, cat separation, licking prevention and swimming or shampoo restrictions create more handling burden than a simple single-site ectoparasiticide.

All five exact presentations are currently registered in Georgia, with a current regulator-hosted product-line leaflet, a transparent assessment dossier and exact-form evidence.

The regulatory dossier and several exact-product controlled or field studies consistently support four-week flea and tick activity plus anti-feeding activity against labelled sand flies and mosquitoes. Some studies are sponsor-linked and bites or attachment are not completely prevented.

Correctly selected dogs generally tolerate the label dose well and canine reactions are very rare, but neurologic signs are possible and permethrin exposure can be fatal to cats. Strict species separation, age, weight, illness and reproductive-use restrictions materially shape safe use.

Monthly weight-band dosing is workable, but application to two to four skin sites, drying time, cat separation, licking prevention and swimming or shampoo restrictions create more handling burden than a simple single-site ectoparasiticide.

The exact 0.4%, 220 ml presentation is actively registered in Georgia and has a current detailed manufacturer page with dose, contact time and repeat interval. No public internationally recognised regulator dossier or independent exact-product trial was found, and its feline claim is not accepted by VetMan without stronger exact-product authorisation.

Permethrin is an established contact insecticide and current authorised dog shampoos support a rinse-off role against fleas. The exact instruction also claims lice and chewing lice, but no controlled exact-product outcome study was found. A shampoo treats parasites present during bathing and cannot by itself control the environmental flea life cycle or provide long-lasting protection.

Dilute rinse-off canine exposure is more controllable than concentrated leave-on permethrin, but exact-formulation margin-of-safety and adverse-event frequency are not publicly characterised. The label excludes dogs under two months, illness/convalescence and pregnancy/lactation. Prevent licking, mucosal exposure and any cat contact with product or wet lather.

Apply 0.5-1 ml/kg to a thoroughly wetted coat, lather over the body while preventing licking, maintain contact for 7-10 minutes, rinse completely, dry and comb. The measurable weight-based range is clear but bathing, restraint and the long contact time are burdensome; repeat only when indicated and no more often than every 10 days.

The product has a current Bulgarian national authorisation with an SPC in the EU Union Product Database and is registered in Georgia (161-11); there is no independent product study.

Permethrin is a proven insecticide and acaricide in dogs, but a rinse-off shampoo kills only parasites present at the bath and leaves little residual protection.

Permethrin is well tolerated by dogs, but the SPC states it is extremely toxic and may be fatal to cats, so treated dogs must be kept away from cats for 72 hours.

Ten to fifteen ml worked into a wet coat for 5-10 minutes, then rinsed and repeated after 2-3 days, is routine but needs two baths.

Exact strength, species, named targets, duration, dose, contraindications, adverse effects and handling are transparent under current Georgian and valid Bulgarian/EU national authorisations. The public SPC text dates from 2013 and no public exact-product assessment or outcome dossier was found; GB/US exact authorisation is absent.

Permethrin spot-on class activity against the named fleas and ticks is credible, but controlled studies used 50-65% formulations or about 50-60 mg/kg, not exact 10%. This product delivers roughly 50 to 6.7 mg/kg within the 2-15 kg band, 13.3 to 6.7 mg/kg at 15-30 kg and still less above 30 kg, so the exact four-week claims—especially in larger dogs—lack an applicable public dose-response bridge.

Dog-specific restrictions, transient local reactions, rare neurologic/GI signs, twofold-overdose observation and decontamination guidance are clear. Yet adverse-event denominators are absent, there is no antidote, pregnancy/lactation and illness/skin-damage exclusions are material, and direct or secondary cat exposure may be fatal despite correct canine intent.

One or two measured millilitres at one or two skin sites and at least 14-day spacing are manageable. The reusable 10 ml bottle needs accurate measurement and two-month tracking; the 15 kg overlap, no-touch/fire precautions, drying, bathing effect and strict 72-hour separation from household cats create substantial real-world handling burden.

The exact 0.3%, 220 ml presentation remains actively registered in Georgia, but the available Russian state-register-derived product record is archived and states that its Russian registration was cancelled; the current VEDA catalogue does not provide an equivalent exact page. Composition and dog regimen are identifiable, but current clinical-source transparency is weak.

Permethrin is an established contact insecticide and authorised dog shampoos support a rinse-off role against fleas, but no controlled exact-product outcome study supports this archived 0.3% formulation. A shampoo treats parasites present during bathing and cannot by itself control the environmental flea life cycle or provide the persistence of modern long-acting alternatives.

The dilute rinse-off dog regimen limits persistence, but exact-formulation adverse-event frequency and margin-of-safety are unavailable. The archived instruction excludes infectious or convalescent animals, nursing females and concurrent insectoacaricides; salivation, tremor or vomiting may follow overdose. Cats must not contact the product or wet treated dog.

Apply 0.5-1 ml/kg to the wetted coat, lather, maintain contact for 3-5 minutes and rinse completely. The shorter contact time helps, but accurate whole-body application, restraint, drying and environmental treatment remain necessary; repeat no more often than every 10 days.

The exact 650 mg/ml product is registered in Georgia and remains valid in the EU regulatory network with a regulator-hosted exact-product SPC, clear composition, dose bands and authorisation history.

The label supports prolonged flea and tick control. A small controlled field study found 100% flea efficacy through day 28 with a 65% permethrin spot-on, and a broad review supports roughly four-week tick activity, but formulation-dependent variability and limited exact-product comparative evidence remain.

Correctly dosed canine use is generally well tolerated, with temporary application-site irritation identified by the product information and no clinical signs in the small 65% permethrin field study. The severe and potentially fatal hazard to cats makes species separation and residue control essential.

Weight-banded one-time application is straightforward, but medium and large dogs require two or three applicators at multiple dorsal sites. Wetting or shampooing requires repeat treatment, with at least seven days between applications, and treated dogs must be separated from cats until dry.

The exact presentation is actively registered in Georgia and has a current manufacturer leaflet. Comparable fipronil-permethrin spot-ons have transparent UK/EU regulatory records, but no public assessment dossier or independent exact-WOW formulation review was found.

Randomised and field studies of closely comparable fipronil-permethrin spot-ons support flea, tick, mosquito and sand-fly activity over the monthly interval. None tested this exact WOW concentration, excipients or manufacturing process, so broad label transfer remains indirect.

Correctly used fipronil-permethrin spot-ons are generally tolerated by dogs, but transient skin or neurologic/gastrointestinal signs can occur. Permethrin exposure can cause fatal convulsions in cats, making household separation, application control and rapid decontamination critical.

A single 2 ml tube and monthly interval are convenient, but the full dose must reach intact skin at several dorsal points and the treated dog must be kept from cats until completely dry.

The exact presentation is actively registered in Georgia and has a current manufacturer leaflet. Comparable fipronil-permethrin spot-ons have transparent UK/EU regulatory records, but no public assessment dossier or independent exact-WOW formulation review was found.

Randomised and field studies of closely comparable fipronil-permethrin spot-ons support flea, tick, mosquito and sand-fly activity over the monthly interval. None tested this exact WOW concentration, excipients or manufacturing process, so broad label transfer remains indirect.

Correctly used fipronil-permethrin spot-ons are generally tolerated by dogs, but transient skin or neurologic/gastrointestinal signs can occur. Permethrin exposure can cause fatal convulsions in cats, making household separation, application control and rapid decontamination critical.

A single 4 ml tube avoids arithmetic, but distributing the full volume over several dorsal points, preventing licking and separating household cats increases owner burden.

The exact presentation is actively registered in Georgia and has a current manufacturer leaflet. Comparable fipronil-permethrin spot-ons have transparent UK/EU regulatory records, but no public assessment dossier or independent exact-WOW formulation review was found.

Randomised and field studies of closely comparable fipronil-permethrin spot-ons support flea, tick, mosquito and sand-fly activity over the monthly interval. None tested this exact WOW concentration, excipients or manufacturing process, so broad label transfer remains indirect.

Correctly used fipronil-permethrin spot-ons are generally tolerated by dogs, but transient skin or neurologic/gastrointestinal signs can occur. Permethrin exposure can cause fatal convulsions in cats, making household separation, application control and rapid decontamination critical.

The 6 ml tube avoids calculation but has the highest application-volume burden; complete skin delivery over several dorsal points and strict cat separation are essential.